ticker
stringlengths 1
10
| date
timestamp[ns] | client
stringlengths 1
80
| client_description
stringlengths 2
114
⌀ | spend
float64 0
25.9M
| transaction_type
stringclasses 7
values | filing_type
stringclasses 7
values | lobby_description
listlengths 0
34
| issue_codes
listlengths 1
34
⌀ | government_entity_details
listlengths 1
725
⌀ | quarter
stringclasses 66
values | effective_date
stringlengths 10
10
| termination_date
stringlengths 10
10
⌀ | client_state
stringclasses 56
values | client_country
stringclasses 40
values | client_id
int64 12
10M
| government_lobby
float64 0
1
⌀ | performing_own_lobbying
float64 0
1
⌀ | registrant_dt_updated
stringlengths 32
32
| registrant_name
stringlengths 3
99
| registrant_address
stringlengths 32
87
| registrant_id
int64 33
401M
| registrant_description
stringlengths 2
103
⌀ | registrant_contact_name
stringlengths 0
34
| registrant_house_registrant_id
float64 12.7k
401M
⌀ | registrant_contact_telephone
stringlengths 0
16
| lobbyist_full_names
listlengths 1
272
⌀ | lobbyist_ids
listlengths 1
272
⌀ | previous_goverment_positions
listlengths 1
272
⌀ | lobbyist_new_statuses
listlengths 1
272
⌀ | client_url
stringlengths 44
45
| registrant_url
stringlengths 45
52
| filing_url
stringlengths 88
88
| filing_id
stringlengths 36
36
| unique_id
stringlengths 46
53
| match
stringlengths 1
80
| date_time
timestamp[ns] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4755
| 2024-04-20T00:00:00
|
medical device manufacturers association
|
Trade association
| 10,000
|
lobbying_income
|
service_provided
|
[
"EPA regulation of EtO"
] |
[
"ENV - Environment/Superfund"
] |
[
"23 - Agriculture, Dept of (USDA)",
"25 - Defense, Dept of (DOD)",
"33 - Energy, Dept of",
"49 - Environmental Protection Agency (EPA)",
"11 - Executive Office of the President (EOP)"
] |
2024-Q1
|
2023-01-20
| null |
DC
|
US
| 54,532
| null | 0
|
2024-07-31T18:57:45.494590-04:00
|
POLICY NAVIGATION GROUP
|
8603 Virginia Ave, Annandale, VA, 22003, US
| 292,094
|
Consulting firm
|
JONATHAN GLEDHILL
| 37,280
|
+1 703-280-0430
|
[
"JONATHAN D GLEDHILL"
] |
[
120524
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/54532/
|
https://lda.senate.gov/api/v1/registrants/292094/
|
https://lda.senate.gov/filings/public/filing/ddeab17c-a665-402a-b926-2e6ceeb3a3ce/print/
|
ddeab17c-a665-402a-b926-2e6ceeb3a3ce
|
ddeab17c-a665-402a-b926-2e6ceeb3a3ce_292094_54532
|
medical device manufacturers association
| 2024-04-20T09:56:12
|
4755
| 2024-04-22T00:00:00
|
medical device manufacturers association
|
trade association for medical device manufacturers
| 20,000
|
lobbying_income
|
service_provided
|
[
"Issues related to GPO safe harbor.",
"Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies."
] |
[
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] |
[
"136 - Centers For Medicare and Medicaid Services (CMS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"136 - Centers For Medicare and Medicaid Services (CMS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2024-Q1
|
2010-01-01
| null |
DC
|
US
| 90
| 0
| 0
|
2024-07-30T12:57:34.693739-04:00
|
THORN RUN PARTNERS
|
100 M Street, SE, Suite 750, Washington, DC, 20003, US
| 400,534,596
|
Government Affairs Firm
|
W. CHRISTOPHER LAMOND
| null |
+1 202-688-0225
|
[
"GARY PALMQUIST",
"MICHAEL O'SHEA MCCARTHY",
"ANDREW ROSENBERG",
"GARY PALMQUIST (Legislative Director: Rep. Dennis Cardoza, Rep. Bob Clement, Rep. Ken Bentsen)",
"MICHAEL O'SHEA MCCARTHY",
"ANDREW ROSENBERG"
] |
[
52116,
58218,
50816,
52116,
58218,
50816
] |
[
null,
null,
null,
"Legislative Director: Rep. Dennis Cardoza, Rep. Bob Clement, Rep. Ken Bentsen",
null,
null
] |
[
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/192498/
|
https://lda.senate.gov/api/v1/registrants/400534596/
|
https://lda.senate.gov/filings/public/filing/55e2fd79-7550-408b-b041-40ecedc4293d/print/
|
55e2fd79-7550-408b-b041-40ecedc4293d
|
55e2fd79-7550-408b-b041-40ecedc4293d_400534596_192498
|
medical device manufacturers association
| 2024-04-22T21:26:01
|
4755
| 2024-04-22T00:00:00
|
medical device manufacturers association
|
Trade association for medical device manufacturers.
| 10,000
|
lobbying_income
|
service_provided
|
[
"Health programs impacting MDMA. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, Ethylene Oxide (EtO), TCET."
] |
[
"HCR - Health Issues"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2024-Q1
|
2024-03-01
| null |
DC
|
US
| 59,580
| null | 0
|
2024-07-11T13:53:53.887825-04:00
|
LMH STRATEGIC SOLUTIONS
|
2231 48th Street NW, Washington, DC, 20007, US
| 401,108,183
| null |
ALANNA TEMME
| null |
+1 202-503-5189
|
[
"ALANNA TEMME (Legislative Director, U.S. Representative Jon Porter)"
] |
[
145804
] |
[
"Legislative Director, U.S. Representative Jon Porter"
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/59580/
|
https://lda.senate.gov/api/v1/registrants/401108183/
|
https://lda.senate.gov/filings/public/filing/b6ad744d-6b4f-476f-bba2-76f9af9a4371/print/
|
b6ad744d-6b4f-476f-bba2-76f9af9a4371
|
b6ad744d-6b4f-476f-bba2-76f9af9a4371_401108183_59580
|
medical device manufacturers association
| 2024-04-22T23:20:24
|
4755
| 2024-04-22T00:00:00
|
medical device manufacturers association
|
Trade association for medical device manufacturers
| 40,000
|
lobbying_income
|
service_provided
|
[
"Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC)."
] |
[
"MMM - Medicare/Medicaid"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2024-Q1
|
2008-09-01
| null |
DC
|
US
| 303
| 0
| 0
|
2024-08-23T13:57:24.400351-04:00
|
THE MCMANUS GROUP
|
610 10th St. NW, Suite 300, Washington, DC, 20001, US
| 286,096
|
Consulting
|
NATE GASPAR
| 36,969
|
+1 434-989-7548
|
[
"LAWREN D GEER",
"JOHN MCMANUS"
] |
[
139187,
9573
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/176447/
|
https://lda.senate.gov/api/v1/registrants/286096/
|
https://lda.senate.gov/filings/public/filing/45519ebe-db06-4a75-a24f-a2f6107aba7b/print/
|
45519ebe-db06-4a75-a24f-a2f6107aba7b
|
45519ebe-db06-4a75-a24f-a2f6107aba7b_286096_176447
|
medical device manufacturers association
| 2024-04-23T00:14:47
|
48273U10
| 2007-08-14T00:00:00
|
k-12
| null | 5,000
|
lobbying_income
|
terminate_retainer
|
[] | null | null |
2009-Q4
|
2007-08-14
|
2009-12-31
|
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
| null | null | null | null |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/ba1e1b58-d42f-4355-880c-8e5712a263a9/print/
|
ba1e1b58-d42f-4355-880c-8e5712a263a9
|
ba1e1b58-d42f-4355-880c-8e5712a263a9_61174_161491
|
k-12
| null |
48273U10
| 2008-04-15T00:00:00
|
k-12
| null | 10,000
|
lobbying_income
|
service_provided
|
[
"H.R. 2204 - No Child Left Behind Reform Act - Title III Improving Teacher Prepartion; S. 1339 - No Child Left Behind Reform Act - Title III Improving Teacher Preparation"
] |
[
"EDU - Education"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q1
|
2007-08-14
| null |
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
|
[
"LINDSAY ANNE LAWRENCE"
] |
[
43386
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/5a4bf47e-b6e5-44cb-97db-20e7dafdfc44/print/
|
5a4bf47e-b6e5-44cb-97db-20e7dafdfc44
|
5a4bf47e-b6e5-44cb-97db-20e7dafdfc44_61174_161491
|
k-12
| 2008-04-15T21:27:38
|
48273U10
| 2008-07-16T00:00:00
|
k-12
| null | 50,000
|
lobbying_income
|
service_provided
|
[
"H.R. 2204 - No Child Left Behind Reform Act - Title III Improving Teacher Preparation; S. 1339-No Child Left Behind Act-Title III Improving Teacher Preparation."
] |
[
"EDU - Education"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q2
|
2007-08-14
| null |
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
|
[
"LINDSAY ANNE LAWRENCE",
"GAVIN CLINGHAM"
] |
[
43386,
30371
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/03199054-6337-4a70-82b2-9a6599501026/print/
|
03199054-6337-4a70-82b2-9a6599501026
|
03199054-6337-4a70-82b2-9a6599501026_61174_161491
|
k-12
| 2008-07-16T20:00:47
|
48273U10
| 2008-10-20T00:00:00
|
k-12
| null | 40,000
|
lobbying_income
|
service_provided
|
[
"H.R. 2204 - No Child Left Behind Reform Act- Title III Improving Teacher Preparations; S. 1339 - No Child Left Behind Act-Title III Improving Teacher Preparation."
] |
[
"EDU - Education"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q3
|
2007-08-14
| null |
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
|
[
"LINDSAY ANNE LAWRENCE",
"GAVIN CLINGHAM"
] |
[
43386,
30371
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/9d8c0487-6282-45bc-8669-f1d2852a4f6a/print/
|
9d8c0487-6282-45bc-8669-f1d2852a4f6a
|
9d8c0487-6282-45bc-8669-f1d2852a4f6a_61174_161491
|
k-12
| 2008-10-20T16:54:23
|
48273U10
| 2009-01-21T00:00:00
|
k-12
| null | 30,000
|
lobbying_income
|
service_provided
|
[
"H.R. 2202 - No Child Left Behind Reform Act-Title III Improving Teacher Preparations; S1339 - No CHild Left Behind Act - Title III Improving Teacher Preparation."
] |
[
"EDU - Education"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q4
|
2007-08-14
| null |
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
|
[
"LINDSAY ANNE LAWRENCE",
"GAVIN CLINGHAM"
] |
[
43386,
30371
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/d0d09d62-c25c-4cd1-8188-b71d4476c058/print/
|
d0d09d62-c25c-4cd1-8188-b71d4476c058
|
d0d09d62-c25c-4cd1-8188-b71d4476c058_61174_161491
|
k-12
| 2009-01-21T18:24:40
|
48273U10
| 2009-04-20T00:00:00
|
k-12
| null | 30,000
|
lobbying_income
|
service_provided
|
[
"H.R. 2202 - No Child Left Behind Reform Act - Tite III Improving Teacher Preparations; S1339 - No Child Left Behind Act - Title III Improving Teacher Preparation."
] |
[
"EDU - Education"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2009-Q1
|
2007-08-14
| null |
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
|
[
"LINDSAY VIDENIEKS"
] |
[
46082
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/e041ea67-1bed-44fb-bc82-4b7dc579e202/print/
|
e041ea67-1bed-44fb-bc82-4b7dc579e202
|
e041ea67-1bed-44fb-bc82-4b7dc579e202_61174_161491
|
k-12
| 2009-04-20T14:13:36
|
48273U10
| 2009-07-20T00:00:00
|
k-12
| null | 30,000
|
lobbying_income
|
service_provided
|
[
"H.R. 2202 - No Child Left Behind Reform Act - Title III Improving Teacher Preparation; S1339 - No Child Left Behind Act - Title III Improving Teacher Preparation"
] |
[
"EDU - Education"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2009-Q2
|
2007-08-14
| null |
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
|
[
"LINDSAY VIDENIEKS"
] |
[
46082
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/746dcbae-a829-4a1f-ac44-b589a774089a/print/
|
746dcbae-a829-4a1f-ac44-b589a774089a
|
746dcbae-a829-4a1f-ac44-b589a774089a_61174_161491
|
k-12
| 2009-07-20T18:13:03
|
48273U10
| 2009-10-19T00:00:00
|
k-12
| null | 5,000
|
lobbying_income
|
retainer
|
[] | null | null |
2009-Q3
|
2007-08-14
| null |
VA
|
US
| 1,014
| 0
| 0
|
2024-02-01T09:26:07.832618-05:00
|
DCI GROUP, L.L.C.
|
2000 K Street, NW, 9th Floor, Washington, DC, 20006, US
| 61,174
|
Public affairs
|
REBECCA NEVILLE
| 36,371
|
+1 202-777-1566
| null | null | null | null |
https://lda.senate.gov/api/v1/clients/161491/
|
https://lda.senate.gov/api/v1/registrants/61174/
|
https://lda.senate.gov/filings/public/filing/91ce2cf1-a088-4444-a3dd-a1108c9e90e6/print/
|
91ce2cf1-a088-4444-a3dd-a1108c9e90e6
|
91ce2cf1-a088-4444-a3dd-a1108c9e90e6_61174_161491
|
k-12
| 2009-10-19T18:36:13
|
48576U10
| 2019-01-23T00:00:00
|
karyopharm therapeutics inc.,
|
Pharmaceutical company
| 60,000
|
lobbying_income
|
service_provided
|
[
"Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2018-Q4
|
2018-11-15
| null |
MA
|
US
| 1,007,678
| 0
| null |
2024-01-30T10:46:25.452471-05:00
|
BGR GOVERNMENT AFFAIRS
|
601 13th Street, NW, 11th Floor South, Washington, DC, 20005, US
| 5,357
|
Lobbying firm
|
CHELSEA MINCHEFF
| 31,564
|
+1 202-661-6385
|
[
"DAVID BOYER (See prior filing)",
"ROBB WALTON (See prior filing)",
"BRENT ALAN DEL MONTE (See prior filing)",
"JOHN STONE (See prior filing)",
"MATT HOFFMANN (See prior filing)",
"REMY LEIGH BRIM MASON (See prior filing)"
] |
[
54906,
65427,
62729,
67545,
69170,
143823
] |
[
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing"
] |
[
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/106759/
|
https://lda.senate.gov/api/v1/registrants/5357/
|
https://lda.senate.gov/filings/public/filing/3be7a2ab-8b39-4d0e-b26f-d058cb842e35/print/
|
3be7a2ab-8b39-4d0e-b26f-d058cb842e35
|
3be7a2ab-8b39-4d0e-b26f-d058cb842e35_5357_106759
|
karyopharm therapeutics inc.,
| 2019-01-23T18:29:48
|
48576U10
| 2019-04-22T00:00:00
|
karyopharm therapeutics inc.,
|
Pharmaceutical company
| 60,000
|
lobbying_income
|
service_provided
|
[
"Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2019-Q1
|
2018-11-15
| null |
MA
|
US
| 1,007,678
| 0
| null |
2024-01-30T10:46:25.452471-05:00
|
BGR GOVERNMENT AFFAIRS
|
601 13th Street, NW, 11th Floor South, Washington, DC, 20005, US
| 5,357
|
Lobbying firm
|
CHELSEA MINCHEFF
| 31,564
|
+1 202-661-6385
|
[
"REMY LEIGH BRIM MASON (See prior filing)",
"DAVID BOYER (See prior filing)",
"ROBB WALTON (See prior filing)",
"BRENT ALAN DEL MONTE (See prior filing)",
"JOHN STONE (See prior filing)",
"MATT HOFFMANN (See prior filing)"
] |
[
143823,
54906,
65427,
62729,
67545,
69170
] |
[
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing"
] |
[
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/106759/
|
https://lda.senate.gov/api/v1/registrants/5357/
|
https://lda.senate.gov/filings/public/filing/1c7179d6-c749-420a-ac7c-c095df3c5420/print/
|
1c7179d6-c749-420a-ac7c-c095df3c5420
|
1c7179d6-c749-420a-ac7c-c095df3c5420_5357_106759
|
karyopharm therapeutics inc.,
| 2019-04-22T19:53:41
|
48576U10
| 2019-07-22T00:00:00
|
karyopharm therapeutics inc.,
|
Pharmaceutical company
| 60,000
|
lobbying_income
|
service_provided
|
[
"Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2019-Q2
|
2018-11-15
| null |
MA
|
US
| 1,007,678
| 0
| null |
2024-01-30T10:46:25.452471-05:00
|
BGR GOVERNMENT AFFAIRS
|
601 13th Street, NW, 11th Floor South, Washington, DC, 20005, US
| 5,357
|
Lobbying firm
|
CHELSEA MINCHEFF
| 31,564
|
+1 202-661-6385
|
[
"REMY LEIGH BRIM MASON (See prior filing)",
"BRENT ALAN DEL MONTE (See prior filing)",
"JOHN STONE (See prior filing)",
"MATT HOFFMANN (See prior filing)",
"DAVID BOYER (See prior filing)",
"ROBB WALTON (See prior filing)"
] |
[
143823,
62729,
67545,
69170,
54906,
65427
] |
[
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing"
] |
[
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/106759/
|
https://lda.senate.gov/api/v1/registrants/5357/
|
https://lda.senate.gov/filings/public/filing/2f6b0ce2-12cc-44ae-9086-4e2fa1fc6cd1/print/
|
2f6b0ce2-12cc-44ae-9086-4e2fa1fc6cd1
|
2f6b0ce2-12cc-44ae-9086-4e2fa1fc6cd1_5357_106759
|
karyopharm therapeutics inc.,
| 2019-07-22T15:28:52
|
48576U10
| 2019-10-21T00:00:00
|
karyopharm therapeutics inc.,
|
Pharmaceutical company
| 60,000
|
lobbying_income
|
service_provided
|
[
"Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2019-Q3
|
2018-11-15
| null |
MA
|
US
| 1,007,678
| 0
| null |
2024-01-30T10:46:25.452471-05:00
|
BGR GOVERNMENT AFFAIRS
|
601 13th Street, NW, 11th Floor South, Washington, DC, 20005, US
| 5,357
|
Lobbying firm
|
CHELSEA MINCHEFF
| 31,564
|
+1 202-661-6385
|
[
"ROBB WALTON (See prior filing)",
"BRENT ALAN DEL MONTE (See prior filing)",
"JOHN STONE (See prior filing)",
"MATT HOFFMANN (See prior filing)",
"REMY LEIGH BRIM MASON (See prior filing)"
] |
[
65427,
62729,
67545,
69170,
143823
] |
[
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing"
] |
[
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/106759/
|
https://lda.senate.gov/api/v1/registrants/5357/
|
https://lda.senate.gov/filings/public/filing/faedc621-e490-4353-9d5a-a262d4f96d6c/print/
|
faedc621-e490-4353-9d5a-a262d4f96d6c
|
faedc621-e490-4353-9d5a-a262d4f96d6c_5357_106759
|
karyopharm therapeutics inc.,
| 2019-10-22T02:51:24
|
48576U10
| 2020-01-21T00:00:00
|
karyopharm therapeutics inc.,
|
Pharmaceutical company
| 40,000
|
lobbying_income
|
terminate
|
[
"Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2019-Q4
|
2018-11-15
|
2019-12-31
|
MA
|
US
| 1,007,678
| 0
| null |
2024-01-30T10:46:25.452471-05:00
|
BGR GOVERNMENT AFFAIRS
|
601 13th Street, NW, 11th Floor South, Washington, DC, 20005, US
| 5,357
|
Lobbying firm
|
CHELSEA MINCHEFF
| 31,564
|
+1 202-661-6385
|
[
"ROBB WALTON (See prior filing)",
"BRENT ALAN DEL MONTE (See prior filing)",
"JOHN STONE (See prior filing)",
"MATT HOFFMANN (See prior filing)",
"REMY LEIGH BRIM MASON (See prior filing)"
] |
[
65427,
62729,
67545,
69170,
143823
] |
[
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing",
"See prior filing"
] |
[
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/106759/
|
https://lda.senate.gov/api/v1/registrants/5357/
|
https://lda.senate.gov/filings/public/filing/2feff692-4153-4099-9698-d7bda1865f26/print/
|
2feff692-4153-4099-9698-d7bda1865f26
|
2feff692-4153-4099-9698-d7bda1865f26_5357_106759
|
karyopharm therapeutics inc.,
| 2020-01-21T19:54:29
|
49460W20
| 2011-01-26T00:00:00
|
kinetic concepts inc.
|
Healthcare technology manufacturer; Medicare DMEPOS supplier
| 30,000
|
lobbying_income
|
service_provided
|
[
"Negative Pressure Wound Therapy under Round 2 DMEPOS competitive bidding"
] |
[
"MMM - Medicare/Medicaid"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q4
|
2011-01-26
| null |
TX
|
US
| 36
| 0
| 0
|
2024-04-02T12:00:21.462428-04:00
|
THE ROSS GROUP, LLC
|
6606 29th Street North, Arlington, VA, 22213, US
| 400,432,094
|
policy and consulting
|
THE ROSS GROUP, LLC
| 400,432,094
|
+1 202-669-5324
|
[
"SHALLA ROSS (see prior filing)"
] |
[
47908
] |
[
"see prior filing"
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/190865/
|
https://lda.senate.gov/api/v1/registrants/400432094/
|
https://lda.senate.gov/filings/public/filing/dde84506-a7e9-48c3-9fb7-65019f7db42f/print/
|
dde84506-a7e9-48c3-9fb7-65019f7db42f
|
dde84506-a7e9-48c3-9fb7-65019f7db42f_400432094_190865
|
kinetic concepts inc.
| null |
49460W20
| 2011-04-19T00:00:00
|
kinetic concepts inc.
|
Healthcare technology manufacturer; Medicare DMEPOS supplier
| 10,000
|
lobbying_income
|
service_provided
|
[
"Medicare Reimbursement; DMEPOS Competitive Bidding"
] |
[
"MMM - Medicare/Medicaid"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q1
|
2011-01-26
| null |
TX
|
US
| 36
| 0
| 0
|
2024-04-02T12:00:21.462428-04:00
|
THE ROSS GROUP, LLC
|
6606 29th Street North, Arlington, VA, 22213, US
| 400,432,094
|
policy and consulting
|
THE ROSS GROUP, LLC
| 400,432,094
|
+1 202-669-5324
|
[
"SHALLA ROSS (Pryce)"
] |
[
47908
] |
[
"Pryce"
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/190865/
|
https://lda.senate.gov/api/v1/registrants/400432094/
|
https://lda.senate.gov/filings/public/filing/b93299e0-be0a-415e-84eb-9ac7c0be66dc/print/
|
b93299e0-be0a-415e-84eb-9ac7c0be66dc
|
b93299e0-be0a-415e-84eb-9ac7c0be66dc_400432094_190865
|
kinetic concepts inc.
| 2011-04-19T16:56:19
|
49460W20
| 2011-06-01T00:00:00
|
kinetic concepts incorporated
|
Wound healing therapies and technologies
| 10,000
|
lobbying_income
|
service_provided
|
[
"Military healthcare wound healing technologies and therapies"
] |
[
"DEF - Defense"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q4
|
2011-06-01
| null |
TX
|
US
| 188
| 0
| 0
|
2022-04-06T16:08:10.970793-04:00
|
CAPITOL CONSULTING GROUP, LLC
|
59 Beaver Lodge Road, Stafford, VA, 22556, US
| 400,366,700
|
Government relations, legislative counsel, and business development
|
PATRICK HIU
| 400,366,700
|
+1 703-576-7015
|
[
"PATRICK HIU",
"LYNN HENSELMAN"
] |
[
46938,
45654
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/189664/
|
https://lda.senate.gov/api/v1/registrants/400366700/
|
https://lda.senate.gov/filings/public/filing/a4345bf2-4082-466e-a8c9-9de72d07885f/print/
|
a4345bf2-4082-466e-a8c9-9de72d07885f
|
a4345bf2-4082-466e-a8c9-9de72d07885f_400366700_189664
|
kinetic concepts incorporated
| null |
49460W20
| 2011-07-19T00:00:00
|
kinetic concepts inc.
|
Healthcare technology manufacturer; Medicare DMEPOS supplier
| 30,000
|
lobbying_income
|
service_provided
|
[
"Medicare Reimbursement; DMEPOS Competititve Bidding"
] |
[
"MMM - Medicare/Medicaid"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q2
|
2011-01-26
| null |
TX
|
US
| 36
| 0
| 0
|
2024-04-02T12:00:21.462428-04:00
|
THE ROSS GROUP, LLC
|
6606 29th Street North, Arlington, VA, 22213, US
| 400,432,094
|
policy and consulting
|
THE ROSS GROUP, LLC
| 400,432,094
|
+1 202-669-5324
|
[
"SHALLA ROSS (see prior filing)"
] |
[
47908
] |
[
"see prior filing"
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/190865/
|
https://lda.senate.gov/api/v1/registrants/400432094/
|
https://lda.senate.gov/filings/public/filing/f5bb39ed-ef63-47fa-9548-eb1aef535141/print/
|
f5bb39ed-ef63-47fa-9548-eb1aef535141
|
f5bb39ed-ef63-47fa-9548-eb1aef535141_400432094_190865
|
kinetic concepts inc.
| 2011-07-19T15:45:20
|
49460W20
| 2011-07-21T00:00:00
|
kinetic concepts incorporated
|
Wound healing therapies and technologies
| 5,000
|
lobbying_income
|
retainer
|
[] | null | null |
2011-Q2
|
2011-06-01
| null |
TX
|
US
| 188
| 0
| 0
|
2022-04-06T16:08:10.970793-04:00
|
CAPITOL CONSULTING GROUP, LLC
|
59 Beaver Lodge Road, Stafford, VA, 22556, US
| 400,366,700
|
Government relations, legislative counsel, and business development
|
PATRICK HIU
| 400,366,700
|
+1 703-576-7015
| null | null | null | null |
https://lda.senate.gov/api/v1/clients/189664/
|
https://lda.senate.gov/api/v1/registrants/400366700/
|
https://lda.senate.gov/filings/public/filing/b65ba40e-2ad1-49a1-b244-70988b183c65/print/
|
b65ba40e-2ad1-49a1-b244-70988b183c65
|
b65ba40e-2ad1-49a1-b244-70988b183c65_400366700_189664
|
kinetic concepts incorporated
| 2011-07-21T21:19:36
|
49460W20
| 2011-10-10T00:00:00
|
kinetic concepts incorporated
|
Wound healing therapies and technologies
| 5,000
|
lobbying_income
|
modify_retainer
|
[] | null | null |
2011-Q3
|
2011-06-01
| null |
TX
|
US
| 188
| 0
| 0
|
2022-04-06T16:08:10.970793-04:00
|
CAPITOL CONSULTING GROUP, LLC
|
59 Beaver Lodge Road, Stafford, VA, 22556, US
| 400,366,700
|
Government relations, legislative counsel, and business development
|
PATRICK HIU
| 400,366,700
|
+1 703-576-7015
| null | null | null | null |
https://lda.senate.gov/api/v1/clients/189664/
|
https://lda.senate.gov/api/v1/registrants/400366700/
|
https://lda.senate.gov/filings/public/filing/eed552d8-bb75-446e-861d-db7e732cc283/print/
|
eed552d8-bb75-446e-861d-db7e732cc283
|
eed552d8-bb75-446e-861d-db7e732cc283_400366700_189664
|
kinetic concepts incorporated
| 2011-10-10T13:07:17
|
49460W20
| 2011-10-19T00:00:00
|
kinetic concepts inc.
|
Healthcare technology manufacturer; Medicare DMEPOS supplier
| 30,000
|
lobbying_income
|
service_provided
|
[
"Accreditation Standards under DMEPOS competitive bidding for Negative Pressure Wound Therapy"
] |
[
"MMM - Medicare/Medicaid"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"198 - Natl Economic Council (NEC)",
"1 - SENATE"
] |
2011-Q3
|
2011-01-26
| null |
TX
|
US
| 36
| 0
| 0
|
2024-04-02T12:00:21.462428-04:00
|
THE ROSS GROUP, LLC
|
6606 29th Street North, Arlington, VA, 22213, US
| 400,432,094
|
policy and consulting
|
THE ROSS GROUP, LLC
| 400,432,094
|
+1 202-669-5324
|
[
"SHALLA ROSS (see prior filing)"
] |
[
47908
] |
[
"see prior filing"
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/190865/
|
https://lda.senate.gov/api/v1/registrants/400432094/
|
https://lda.senate.gov/filings/public/filing/694b1808-3765-4d03-a592-64f2b19dc965/print/
|
694b1808-3765-4d03-a592-64f2b19dc965
|
694b1808-3765-4d03-a592-64f2b19dc965_400432094_190865
|
kinetic concepts inc.
| 2011-10-20T00:19:28
|
49460W20
| 2012-04-14T00:00:00
|
kinetic concepts incorporated
|
Wound healing therapies and technologies
| 5,000
|
lobbying_income
|
terminate_retainer
|
[] | null | null |
2012-Q1
|
2011-06-01
|
2012-03-31
|
TX
|
US
| 188
| 0
| 0
|
2022-04-06T16:08:10.970793-04:00
|
CAPITOL CONSULTING GROUP, LLC
|
59 Beaver Lodge Road, Stafford, VA, 22556, US
| 400,366,700
|
Government relations, legislative counsel, and business development
|
PATRICK HIU
| 400,366,700
|
+1 703-576-7015
| null | null | null | null |
https://lda.senate.gov/api/v1/clients/189664/
|
https://lda.senate.gov/api/v1/registrants/400366700/
|
https://lda.senate.gov/filings/public/filing/8ccd0b78-bf2e-4086-bd83-9f7d7f187282/print/
|
8ccd0b78-bf2e-4086-bd83-9f7d7f187282
|
8ccd0b78-bf2e-4086-bd83-9f7d7f187282_400366700_189664
|
kinetic concepts incorporated
| 2012-04-14T22:34:42
|
49460W20
| 2012-04-20T00:00:00
|
kinetic concepts inc.
|
Healthcare technology manufacturer; Medicare DMEPOS supplier
| 30,000
|
lobbying_income
|
terminate
|
[
"Quality Standards for Negative Pressure Wound Therapy DMEPOS Competitive Bidding Round 2"
] |
[
"MMM - Medicare/Medicaid"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2012-Q1
|
2011-01-26
|
2012-03-31
|
TX
|
US
| 36
| 0
| 0
|
2024-04-02T12:00:21.462428-04:00
|
THE ROSS GROUP, LLC
|
6606 29th Street North, Arlington, VA, 22213, US
| 400,432,094
|
policy and consulting
|
THE ROSS GROUP, LLC
| 400,432,094
|
+1 202-669-5324
|
[
"SHALLA ROSS (See Prior Filing)"
] |
[
47908
] |
[
"See Prior Filing"
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/190865/
|
https://lda.senate.gov/api/v1/registrants/400432094/
|
https://lda.senate.gov/filings/public/filing/3785ec3f-a5be-4f6d-9b63-a8c04224490b/print/
|
3785ec3f-a5be-4f6d-9b63-a8c04224490b
|
3785ec3f-a5be-4f6d-9b63-a8c04224490b_400432094_190865
|
kinetic concepts inc.
| 2012-04-20T16:56:59
|
4991
| 2010-04-09T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 10,000
|
lobbying_income
|
service_provided
|
[
"FY2011 Department of Defense Appropriations, issues pertaining to RDT&E.",
"FY2011 Department of Defense Appropriations, issues pertaining to RDT&E.",
"Issues related to perimeter and border security."
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations",
"INT - Intelligence"
] |
[
"201 - Homeland Security, Dept of (DHS)",
"2 - HOUSE OF REPRESENTATIVES",
"127 - Natl Security Agency (NSA)",
"1 - SENATE",
"39 - State, Dept of (DOS)",
"201 - Homeland Security, Dept of (DHS)",
"2 - HOUSE OF REPRESENTATIVES",
"127 - Natl Security Agency (NSA)",
"1 - SENATE",
"39 - State, Dept of (DOS)",
"201 - Homeland Security, Dept of (DHS)",
"2 - HOUSE OF REPRESENTATIVES",
"127 - Natl Security Agency (NSA)",
"1 - SENATE",
"39 - State, Dept of (DOS)"
] |
2010-Q1
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"JUDITH HAFNER",
"MARK BAKER",
"JUDITH HAFNER",
"MARK BAKER",
"JUDITH HAFNER"
] |
[
28513,
21630,
28513,
21630,
28513
] |
[
null,
null,
null,
null,
null
] |
[
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/53fba97f-f13e-468e-afbf-1579fcd9a3c5/print/
|
53fba97f-f13e-468e-afbf-1579fcd9a3c5
|
53fba97f-f13e-468e-afbf-1579fcd9a3c5_25328_133149
|
gcs holdings inc.
| 2010-04-09T18:35:31
|
4991
| 2010-07-13T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 10,000
|
lobbying_income
|
service_provided
|
[
"Issues pertaining to perimeter security at nuclear facilities.",
"FY2011 Dept. of Defense Appropriations, issues pertaining to RDT&E. Issues pertaining to perimeter security.",
"FY2011 Dept. of Defense Appropriations, issues pertaining to RDT&E",
"Issues related to perimeter and border security"
] |
[
"ENG - Energy/Nuclear",
"DEF - Defense",
"BUD - Budget/Appropriations",
"INT - Intelligence"
] |
[
"25 - Defense, Dept of (DOD)",
"33 - Energy, Dept of",
"201 - Homeland Security, Dept of (DHS)",
"127 - Natl Security Agency (NSA)",
"1 - SENATE",
"39 - State, Dept of (DOS)",
"25 - Defense, Dept of (DOD)",
"33 - Energy, Dept of",
"201 - Homeland Security, Dept of (DHS)",
"127 - Natl Security Agency (NSA)",
"1 - SENATE",
"39 - State, Dept of (DOS)",
"25 - Defense, Dept of (DOD)",
"33 - Energy, Dept of",
"201 - Homeland Security, Dept of (DHS)",
"127 - Natl Security Agency (NSA)",
"1 - SENATE",
"39 - State, Dept of (DOS)",
"25 - Defense, Dept of (DOD)",
"33 - Energy, Dept of",
"201 - Homeland Security, Dept of (DHS)",
"127 - Natl Security Agency (NSA)",
"1 - SENATE",
"39 - State, Dept of (DOS)"
] |
2010-Q2
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"JUDITH HAFNER",
"JUDITH HAFNER",
"MARK BAKER",
"JUDITH HAFNER",
"MARK BAKER",
"DENNY M MILLER",
"JUDITH HAFNER"
] |
[
28513,
28513,
21630,
28513,
21630,
44659,
28513
] |
[
null,
null,
null,
null,
null,
null,
null
] |
[
false,
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/fe04a1ee-d877-42b3-aba8-0e4f59f0dd98/print/
|
fe04a1ee-d877-42b3-aba8-0e4f59f0dd98
|
fe04a1ee-d877-42b3-aba8-0e4f59f0dd98_25328_133149
|
gcs holdings inc.
| 2010-07-13T19:26:26
|
4991
| 2010-10-20T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 10,000
|
lobbying_income
|
service_provided
|
[
"S2800 FY2011 Dept. of Defense, issues pertaining to RDT&E. Issues pertaining to permiter security.",
"S3800 FY2011 Dept. Of Defense Apprpriations, issues pertaining to RDT&E.",
"Issues realted to perimter and border security."
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations",
"INT - Intelligence"
] |
[
"201 - Homeland Security, Dept of (DHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"201 - Homeland Security, Dept of (DHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"201 - Homeland Security, Dept of (DHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2010-Q3
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"JUDITH HAFNER",
"MARK BAKER",
"JUDITH HAFNER",
"MARK BAKER",
"DENNY M MILLER",
"JUDITH HAFNER"
] |
[
28513,
21630,
28513,
21630,
44659,
28513
] |
[
null,
null,
null,
null,
null,
null
] |
[
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/c9744614-360f-4acd-bc79-47c091d63a4b/print/
|
c9744614-360f-4acd-bc79-47c091d63a4b
|
c9744614-360f-4acd-bc79-47c091d63a4b_25328_133149
|
gcs holdings inc.
| 2010-10-20T15:19:48
|
4991
| 2011-01-11T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 10,000
|
lobbying_income
|
service_provided
|
[
"S 3800 FY 2011 Department of Defense Appropriation, issues pertaining to RDT&E, Omnibus",
"S 3800 FY 2011 Department of Defense Appropriation, issues pertaining to RDT&E, Omnibus",
"Issues related to perimeter and border security"
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations",
"HOM - Homeland Security"
] |
[
"201 - Homeland Security, Dept of (DHS)",
"1 - SENATE",
"201 - Homeland Security, Dept of (DHS)",
"1 - SENATE",
"201 - Homeland Security, Dept of (DHS)",
"1 - SENATE"
] |
2010-Q4
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"JUDITH HAFNER",
"MARK BAKER",
"JUDITH HAFNER",
"MARK BAKER",
"DENNY M MILLER",
"JUDITH HAFNER",
"SHAY MICHAEL HANCOCK",
"WALLY BURNETT"
] |
[
28513,
21630,
28513,
21630,
44659,
28513,
43277,
21146
] |
[
null,
null,
null,
null,
null,
null,
null,
null
] |
[
false,
false,
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/a4176c66-b8d3-412d-9b72-77a203d7e4eb/print/
|
a4176c66-b8d3-412d-9b72-77a203d7e4eb
|
a4176c66-b8d3-412d-9b72-77a203d7e4eb_25328_133149
|
gcs holdings inc.
| 2011-01-11T21:40:41
|
4991
| 2011-04-18T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 10,000
|
lobbying_income
|
service_provided
|
[
"Issues pertaining to FY 2011 Defense Appropriations.",
"Issues pertaining to FY 2011 Defense Appropriations."
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q1
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"DENNY M MILLER",
"JUDITH HAFNER",
"MARK BAKER",
"DENNY M MILLER",
"JUDITH HAFNER",
"MARK BAKER"
] |
[
44659,
28513,
21630,
44659,
28513,
21630
] |
[
null,
null,
null,
null,
null,
null
] |
[
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/b4d64525-a32d-4947-b089-62c23cbaf3f2/print/
|
b4d64525-a32d-4947-b089-62c23cbaf3f2
|
b4d64525-a32d-4947-b089-62c23cbaf3f2_25328_133149
|
gcs holdings inc.
| 2011-04-18T19:17:22
|
4991
| 2011-07-18T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 5,000
|
lobbying_income
|
service_provided
|
[
"Issues pertaining to the FY2011 Department of Defense and Full-Year Continuing Appropriations Act, 2011 (Public Law 112-10) and the FY2012 Defense Appropriations Bill (HR 2219).",
"Issues pertaining to the FY2011 Department of Defense and Full-Year Continuing Appropriations Act, 2011 (Public Law 112-10) and the FY2012 Defense Appropriations Bill (HR 2219)."
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations"
] |
[
"1 - SENATE",
"1 - SENATE"
] |
2011-Q2
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"DENNY M MILLER",
"JUDITH HAFNER",
"DENNY M MILLER",
"JUDITH HAFNER"
] |
[
44659,
28513,
44659,
28513
] |
[
null,
null,
null,
null
] |
[
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/65b2f38b-10c2-42e3-9783-7d8a9633adaf/print/
|
65b2f38b-10c2-42e3-9783-7d8a9633adaf
|
65b2f38b-10c2-42e3-9783-7d8a9633adaf_25328_133149
|
gcs holdings inc.
| 2011-07-18T19:39:53
|
4991
| 2011-10-18T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 5,000
|
lobbying_income
|
service_provided
|
[
"Issues pertaining to the Department of Defense Rapid Innovation Fund.",
"Issues pertaining to the Department of Defense Rapid Innovation Fund."
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations"
] |
[
"1 - SENATE",
"1 - SENATE"
] |
2011-Q3
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"JUDITH HAFNER",
"JUDITH HAFNER"
] |
[
28513,
28513
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/da28a0be-abb1-472a-afd5-fdcbe7202d20/print/
|
da28a0be-abb1-472a-afd5-fdcbe7202d20
|
da28a0be-abb1-472a-afd5-fdcbe7202d20_25328_133149
|
gcs holdings inc.
| 2011-10-18T14:36:20
|
4991
| 2012-01-19T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 5,000
|
lobbying_income
|
service_provided
|
[
"Issues pertaining to the Department of Defense Rapid Innovation Fund.",
"Issues pertaining to the Department of Defense Rapid Innovation Fund."
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q4
|
2010-01-01
| null |
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"JUDITH HAFNER",
"DENNY M MILLER",
"JUDITH HAFNER",
"DENNY M MILLER"
] |
[
28513,
44659,
28513,
44659
] |
[
null,
null,
null,
null
] |
[
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/4f43fe5d-9c4b-4d00-90a0-7dd0926bcdd8/print/
|
4f43fe5d-9c4b-4d00-90a0-7dd0926bcdd8
|
4f43fe5d-9c4b-4d00-90a0-7dd0926bcdd8_25328_133149
|
gcs holdings inc.
| 2012-01-19T23:28:45
|
4991
| 2012-04-05T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 0
|
lobbying_income
|
terminate
|
[
"Issues pertaining to the Department of Defense Rapid Innovation Fund.",
"Issues pertaining to the Department of Defense Rapid Innovation Fund."
] |
[
"DEF - Defense",
"BUD - Budget/Appropriations"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2012-Q1
|
2010-01-01
|
2012-03-31
|
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
|
[
"JUDITH HAFNER",
"DENNY M MILLER",
"JUDITH HAFNER",
"DENNY M MILLER"
] |
[
28513,
44659,
28513,
44659
] |
[
null,
null,
null,
null
] |
[
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/87c59734-8c28-4d4a-a3b9-1d600043e2ae/print/
|
87c59734-8c28-4d4a-a3b9-1d600043e2ae
|
87c59734-8c28-4d4a-a3b9-1d600043e2ae_25328_133149
|
gcs holdings inc.
| 2012-04-05T19:53:58
|
4991
| 2012-04-05T00:00:00
|
gcs holdings inc.
|
Geospatial intelligence and surveillance systems
| 5,000
|
lobbying_income
|
modify_termination
|
[] | null | null |
2012-Q1
|
2010-01-01
|
2012-03-31
|
MT
|
US
| 1,005,065
| 0
| 0
|
2022-04-06T16:06:34.952708-04:00
|
DENNY MILLER ASSOCIATES
|
400 N Capitol St, Ste 363, Washington, DC, 20001, US
| 25,328
|
Lobbying, consulting and government relations
|
MELISSA BROWN
| 30,761
|
+1 202-783-0280
| null | null | null | null |
https://lda.senate.gov/api/v1/clients/133149/
|
https://lda.senate.gov/api/v1/registrants/25328/
|
https://lda.senate.gov/filings/public/filing/d370c97d-4d8b-4cab-9da2-0e891d2599d0/print/
|
d370c97d-4d8b-4cab-9da2-0e891d2599d0
|
d370c97d-4d8b-4cab-9da2-0e891d2599d0_25328_133149
|
gcs holdings inc.
| 2012-04-05T20:01:59
|
500091
| 2007-09-05T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2009-Q4
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/aa76d2c0-59f3-45cf-929b-9f4743dd9a2b/print/
|
aa76d2c0-59f3-45cf-929b-9f4743dd9a2b
|
aa76d2c0-59f3-45cf-929b-9f4743dd9a2b_61573_161870
|
core healthcare
| null |
|
500091
| 2008-04-21T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2008-Q1
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/81c85aa3-d1d4-4498-8fc0-b5f40741ae93/print/
|
81c85aa3-d1d4-4498-8fc0-b5f40741ae93
|
81c85aa3-d1d4-4498-8fc0-b5f40741ae93_61573_161870
|
core healthcare
| 2008-04-21T19:16:39
|
|
500091
| 2008-07-15T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
terminate
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2008-Q2
|
2007-09-05
|
2008-06-01
| null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/d44aa62b-3df5-45f4-9f94-d1cb08a857f5/print/
|
d44aa62b-3df5-45f4-9f94-d1cb08a857f5
|
d44aa62b-3df5-45f4-9f94-d1cb08a857f5_61573_161870
|
core healthcare
| 2008-07-15T22:50:11
|
|
500091
| 2008-10-17T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2008-Q3
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/c095b3e5-3619-498c-9637-eb0bf573ee34/print/
|
c095b3e5-3619-498c-9637-eb0bf573ee34
|
c095b3e5-3619-498c-9637-eb0bf573ee34_61573_161870
|
core healthcare
| 2008-10-18T01:17:35
|
|
500091
| 2009-01-20T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2008-Q4
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/6d7589f8-e083-46af-bc2d-6055388fc201/print/
|
6d7589f8-e083-46af-bc2d-6055388fc201
|
6d7589f8-e083-46af-bc2d-6055388fc201_61573_161870
|
core healthcare
| 2009-01-20T18:39:21
|
|
500091
| 2009-04-20T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2009-Q1
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/6560d539-4a13-44f0-97f1-a140dcab6df6/print/
|
6560d539-4a13-44f0-97f1-a140dcab6df6
|
6560d539-4a13-44f0-97f1-a140dcab6df6_61573_161870
|
core healthcare
| 2009-04-20T18:15:34
|
|
500091
| 2009-07-20T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2009-Q2
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/88087c7c-94f2-468b-9aee-023b361adf23/print/
|
88087c7c-94f2-468b-9aee-023b361adf23
|
88087c7c-94f2-468b-9aee-023b361adf23_61573_161870
|
core healthcare
| 2009-07-20T15:32:06
|
|
500091
| 2009-10-20T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] |
[
"42 - Veterans Affairs, Dept of (VA)"
] |
2009-Q3
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/3575fd0e-ad61-4d04-a35d-f527faac394f/print/
|
3575fd0e-ad61-4d04-a35d-f527faac394f
|
3575fd0e-ad61-4d04-a35d-f527faac394f_61573_161870
|
core healthcare
| 2009-10-20T18:57:37
|
|
500091
| 2010-04-15T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Adminisitration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] | null |
2010-Q1
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/a2dc92ce-c3eb-4fd7-92ca-c164b28867ac/print/
|
a2dc92ce-c3eb-4fd7-92ca-c164b28867ac
|
a2dc92ce-c3eb-4fd7-92ca-c164b28867ac_61573_161870
|
core healthcare
| 2010-04-15T19:24:50
|
|
500091
| 2010-07-20T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] | null |
2010-Q2
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/f84a996f-94b3-4535-99ce-f82b9a4ce194/print/
|
f84a996f-94b3-4535-99ce-f82b9a4ce194
|
f84a996f-94b3-4535-99ce-f82b9a4ce194_61573_161870
|
core healthcare
| 2010-07-20T16:50:06
|
|
500091
| 2010-10-14T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] | null |
2010-Q3
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/e25683bd-e8b9-4e60-9440-e5f6a7e9ffe0/print/
|
e25683bd-e8b9-4e60-9440-e5f6a7e9ffe0
|
e25683bd-e8b9-4e60-9440-e5f6a7e9ffe0_61573_161870
|
core healthcare
| 2010-10-15T03:07:20
|
|
500091
| 2011-01-11T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
service_provided
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] | null |
2010-Q4
|
2007-09-05
| null | null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/6e2d763b-1855-4ab2-9967-acaee5ff89c2/print/
|
6e2d763b-1855-4ab2-9967-acaee5ff89c2
|
6e2d763b-1855-4ab2-9967-acaee5ff89c2_61573_161870
|
core healthcare
| 2011-01-11T23:14:52
|
|
500091
| 2011-03-14T00:00:00
|
core healthcare
|
Healthcare facility specializing in brain trauma.
| 5,000
|
lobbying_income
|
terminate
|
[
"Contact the Veterans Administration regarding Core Healthcare services they could provide to Veterans."
] |
[
"HCR - Health Issues"
] | null |
2011-Q1
|
2007-09-05
|
2011-02-28
| null | 1,004,031
| 0
| 0
|
2022-04-06T16:08:25.260380-04:00
|
MS. KAREN JOHNSON
|
1122 Colorado, Suite 300, Austin, TX, 78701, US
| 61,573
|
Consulting and Lobbying work
|
KAREN A. JOHNSON
| 35,412
|
+1 512-478-4584
|
[
"KAREN JOHNSON"
] |
[
20624
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/161870/
|
https://lda.senate.gov/api/v1/registrants/61573/
|
https://lda.senate.gov/filings/public/filing/a2741d02-8bfd-43fa-8595-053676c10443/print/
|
a2741d02-8bfd-43fa-8595-053676c10443
|
a2741d02-8bfd-43fa-8595-053676c10443_61573_161870
|
core healthcare
| 2011-03-14T18:24:24
|
|
500124
| 2014-09-01T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees, NHI, DEA"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2016-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/88709b29-7334-4f8b-b646-c15d84f8d47b/print/
|
88709b29-7334-4f8b-b646-c15d84f8d47b
|
88709b29-7334-4f8b-b646-c15d84f8d47b_315091_185325
|
dr. reddy's laboratories, ltd
| null |
500124
| 2015-01-15T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 36,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2014-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/7d75c19d-2ce7-48d9-ac25-0252d23688a0/print/
|
7d75c19d-2ce7-48d9-ac25-0252d23688a0
|
7d75c19d-2ce7-48d9-ac25-0252d23688a0_315091_185325
|
dr. reddy's laboratories, ltd
| 2015-01-15T00:51:39
|
500124
| 2015-04-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 36,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2015-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/a4feb7c8-cbae-4965-aeb1-7171eb831251/print/
|
a4feb7c8-cbae-4965-aeb1-7171eb831251
|
a4feb7c8-cbae-4965-aeb1-7171eb831251_315091_185325
|
dr. reddy's laboratories, ltd
| 2015-04-20T16:02:20
|
500124
| 2015-07-16T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 36,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2015-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/5a680884-3584-41dc-ab03-1b3ac3c14156/print/
|
5a680884-3584-41dc-ab03-1b3ac3c14156
|
5a680884-3584-41dc-ab03-1b3ac3c14156_315091_185325
|
dr. reddy's laboratories, ltd
| 2015-07-16T17:02:52
|
500124
| 2015-10-21T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 36,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2015-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/1def45e4-0e2c-4e92-b627-fa6918741ecc/print/
|
1def45e4-0e2c-4e92-b627-fa6918741ecc
|
1def45e4-0e2c-4e92-b627-fa6918741ecc_315091_185325
|
dr. reddy's laboratories, ltd
| 2015-10-21T15:41:58
|
500124
| 2016-01-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 15,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2015-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/e5b38dfd-b5e9-48d6-9130-ce1d5b6559d8/print/
|
e5b38dfd-b5e9-48d6-9130-ce1d5b6559d8
|
e5b38dfd-b5e9-48d6-9130-ce1d5b6559d8_315091_185325
|
dr. reddy's laboratories, ltd
| 2016-01-20T22:02:33
|
500124
| 2016-04-18T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 15,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees"
] |
[
"PHA - Pharmacy"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2016-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/db6a4198-6c22-40b9-b2d4-3a8785afc0b6/print/
|
db6a4198-6c22-40b9-b2d4-3a8785afc0b6
|
db6a4198-6c22-40b9-b2d4-3a8785afc0b6_315091_185325
|
dr. reddy's laboratories, ltd
| 2016-04-18T18:09:52
|
500124
| 2016-07-19T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees, NHI, DEA"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2016-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/5efe5505-60e7-4628-9a94-c2551700cc99/print/
|
5efe5505-60e7-4628-9a94-c2551700cc99
|
5efe5505-60e7-4628-9a94-c2551700cc99_315091_185325
|
dr. reddy's laboratories, ltd
| 2016-07-19T15:21:26
|
500124
| 2016-10-19T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Food and Drug Administration, Generic Drug User Fees, NHI, DEA"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2016-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI",
"TODD SMITH"
] |
[
33519,
28656,
53578
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/167a07ac-8ecc-450e-ba2c-393c27a80549/print/
|
167a07ac-8ecc-450e-ba2c-393c27a80549
|
167a07ac-8ecc-450e-ba2c-393c27a80549_315091_185325
|
dr. reddy's laboratories, ltd
| 2016-10-19T14:12:59
|
500124
| 2017-04-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2017-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/ac7880b5-51f2-4682-951d-eeacad9bd44f/print/
|
ac7880b5-51f2-4682-951d-eeacad9bd44f
|
ac7880b5-51f2-4682-951d-eeacad9bd44f_315091_185325
|
dr. reddy's laboratories, ltd
| 2017-04-20T14:34:31
|
500124
| 2017-07-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2017-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/14a00238-ad0b-4dc6-a47b-18de60441ba2/print/
|
14a00238-ad0b-4dc6-a47b-18de60441ba2
|
14a00238-ad0b-4dc6-a47b-18de60441ba2_315091_185325
|
dr. reddy's laboratories, ltd
| 2017-07-21T02:04:30
|
500124
| 2017-10-23T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2017-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/f49d605b-0006-4dc2-9322-8c29df2fb44e/print/
|
f49d605b-0006-4dc2-9322-8c29df2fb44e
|
f49d605b-0006-4dc2-9322-8c29df2fb44e_315091_185325
|
dr. reddy's laboratories, ltd
| 2017-10-23T15:19:31
|
500124
| 2018-01-21T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2017-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/1e06bc4c-1830-4921-9fc2-9b8ed717da1f/print/
|
1e06bc4c-1830-4921-9fc2-9b8ed717da1f
|
1e06bc4c-1830-4921-9fc2-9b8ed717da1f_315091_185325
|
dr. reddy's laboratories, ltd
| 2018-01-21T23:29:00
|
500124
| 2018-04-30T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2018-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/5d2a10c2-0dca-41e7-9e69-e79f08b6c181/print/
|
5d2a10c2-0dca-41e7-9e69-e79f08b6c181
|
5d2a10c2-0dca-41e7-9e69-e79f08b6c181_315091_185325
|
dr. reddy's laboratories, ltd
| 2018-04-30T15:19:47
|
500124
| 2018-07-26T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2018-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/9628792c-b992-46df-b3cc-e1657dda9f43/print/
|
9628792c-b992-46df-b3cc-e1657dda9f43
|
9628792c-b992-46df-b3cc-e1657dda9f43_315091_185325
|
dr. reddy's laboratories, ltd
| 2018-07-26T11:51:26
|
500124
| 2018-10-18T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2018-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/53f8389c-ce29-45ac-b76e-64371bc00b18/print/
|
53f8389c-ce29-45ac-b76e-64371bc00b18
|
53f8389c-ce29-45ac-b76e-64371bc00b18_315091_185325
|
dr. reddy's laboratories, ltd
| 2018-10-18T13:52:08
|
500124
| 2019-01-18T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2018-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/575f8cd4-2428-493e-abae-94b285c79305/print/
|
575f8cd4-2428-493e-abae-94b285c79305
|
575f8cd4-2428-493e-abae-94b285c79305_315091_185325
|
dr. reddy's laboratories, ltd
| 2019-01-18T17:04:26
|
500124
| 2019-04-10T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2019-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/da57a9f4-74fd-4266-83b9-e55a580f32f8/print/
|
da57a9f4-74fd-4266-83b9-e55a580f32f8
|
da57a9f4-74fd-4266-83b9-e55a580f32f8_315091_185325
|
dr. reddy's laboratories, ltd
| 2019-04-10T12:45:21
|
500124
| 2019-07-03T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2019-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/da389119-ede3-4e9e-b809-3d171f89d4f0/print/
|
da389119-ede3-4e9e-b809-3d171f89d4f0
|
da389119-ede3-4e9e-b809-3d171f89d4f0_315091_185325
|
dr. reddy's laboratories, ltd
| 2019-07-03T19:53:41
|
500124
| 2019-10-07T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2019-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/9c0cd06d-4a8d-4dee-a131-0ad15b643148/print/
|
9c0cd06d-4a8d-4dee-a131-0ad15b643148
|
9c0cd06d-4a8d-4dee-a131-0ad15b643148_315091_185325
|
dr. reddy's laboratories, ltd
| 2019-10-07T19:08:26
|
500124
| 2020-01-14T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2019-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/0092fdc9-214a-455e-9b02-462ef0339159/print/
|
0092fdc9-214a-455e-9b02-462ef0339159
|
0092fdc9-214a-455e-9b02-462ef0339159_315091_185325
|
dr. reddy's laboratories, ltd
| 2020-01-14T15:33:53
|
500124
| 2020-04-15T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2020-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/0c67f07c-4d19-41bb-b777-9ca0abbea2b3/print/
|
0c67f07c-4d19-41bb-b777-9ca0abbea2b3
|
0c67f07c-4d19-41bb-b777-9ca0abbea2b3_315091_185325
|
dr. reddy's laboratories, ltd
| 2020-04-15T12:32:38
|
500124
| 2020-07-09T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2020-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/c7a2750e-bc23-4d14-88e8-b6d562e0dac8/print/
|
c7a2750e-bc23-4d14-88e8-b6d562e0dac8
|
c7a2750e-bc23-4d14-88e8-b6d562e0dac8_315091_185325
|
dr. reddy's laboratories, ltd
| 2020-07-09T17:13:57
|
500124
| 2020-10-06T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 45,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2020-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/7af872d3-e3eb-48d0-9ccb-fd16bd792b69/print/
|
7af872d3-e3eb-48d0-9ccb-fd16bd792b69
|
7af872d3-e3eb-48d0-9ccb-fd16bd792b69_315091_185325
|
dr. reddy's laboratories, ltd
| 2020-10-06T15:27:08
|
500124
| 2021-01-18T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2020-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/65a80d41-6856-4cf3-aa1f-665d700ebfa6/print/
|
65a80d41-6856-4cf3-aa1f-665d700ebfa6
|
65a80d41-6856-4cf3-aa1f-665d700ebfa6_315091_185325
|
dr. reddy's laboratories, ltd
| 2021-01-18T18:54:13
|
500124
| 2021-04-15T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2021-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/c53959c7-8f0c-49aa-9821-f8baeed37591/print/
|
c53959c7-8f0c-49aa-9821-f8baeed37591
|
c53959c7-8f0c-49aa-9821-f8baeed37591_315091_185325
|
dr. reddy's laboratories, ltd
| 2021-04-15T16:40:34
|
500124
| 2021-07-15T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2021-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/bf18b12e-53d5-423a-93ef-4e540d6c7ebf/print/
|
bf18b12e-53d5-423a-93ef-4e540d6c7ebf
|
bf18b12e-53d5-423a-93ef-4e540d6c7ebf_315091_185325
|
dr. reddy's laboratories, ltd
| 2021-07-15T13:39:00
|
500124
| 2021-10-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2021-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/6c71f18a-b247-408c-9da6-b8a7bc021ab1/print/
|
6c71f18a-b247-408c-9da6-b8a7bc021ab1
|
6c71f18a-b247-408c-9da6-b8a7bc021ab1_315091_185325
|
dr. reddy's laboratories, ltd
| 2021-10-20T12:49:21
|
500124
| 2022-01-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2021-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE",
"KATHY KULKARNI"
] |
[
33519,
28656
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/c8af8b7d-f30b-4c93-b43e-8177109aa008/print/
|
c8af8b7d-f30b-4c93-b43e-8177109aa008
|
c8af8b7d-f30b-4c93-b43e-8177109aa008_315091_185325
|
dr. reddy's laboratories, ltd
| 2022-01-20T14:33:38
|
500124
| 2022-04-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2022-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/6065a722-539c-4d61-8bef-b33868d67bf4/print/
|
6065a722-539c-4d61-8bef-b33868d67bf4
|
6065a722-539c-4d61-8bef-b33868d67bf4_315091_185325
|
dr. reddy's laboratories, ltd
| 2022-04-20T17:39:45
|
500124
| 2022-07-19T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2022-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/c1390bb2-24d0-4414-a3b2-6087314d6461/print/
|
c1390bb2-24d0-4414-a3b2-6087314d6461
|
c1390bb2-24d0-4414-a3b2-6087314d6461_315091_185325
|
dr. reddy's laboratories, ltd
| 2022-07-19T15:45:44
|
500124
| 2022-10-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2022-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/6511f060-078d-47fd-9e27-740a7a087aa0/print/
|
6511f060-078d-47fd-9e27-740a7a087aa0
|
6511f060-078d-47fd-9e27-740a7a087aa0_315091_185325
|
dr. reddy's laboratories, ltd
| 2022-10-20T18:20:18
|
500124
| 2023-01-16T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2022-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/ed33e658-c5eb-45e0-b742-55e635c2f981/print/
|
ed33e658-c5eb-45e0-b742-55e635c2f981
|
ed33e658-c5eb-45e0-b742-55e635c2f981_315091_185325
|
dr. reddy's laboratories, ltd
| 2023-01-16T12:24:37
|
500124
| 2023-04-20T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2023-Q1
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/e7899696-c0d5-4bc1-8d27-84b7c472fddf/print/
|
e7899696-c0d5-4bc1-8d27-84b7c472fddf
|
e7899696-c0d5-4bc1-8d27-84b7c472fddf_315091_185325
|
dr. reddy's laboratories, ltd
| 2023-04-20T16:28:23
|
500124
| 2023-07-23T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2023-Q2
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/cca670ed-d028-4e26-9bbf-75213999e145/print/
|
cca670ed-d028-4e26-9bbf-75213999e145
|
cca670ed-d028-4e26-9bbf-75213999e145_315091_185325
|
dr. reddy's laboratories, ltd
| 2023-07-23T19:45:51
|
500124
| 2023-10-22T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2023-Q3
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/9928f739-cd33-4ab2-b873-b97591cd3250/print/
|
9928f739-cd33-4ab2-b873-b97591cd3250
|
9928f739-cd33-4ab2-b873-b97591cd3250_315091_185325
|
dr. reddy's laboratories, ltd
| 2023-10-23T01:43:15
|
500124
| 2024-01-25T00:00:00
|
dr. reddy's laboratories, ltd
|
Medical Laboratory
| 60,000
|
lobbying_income
|
service_provided
|
[
"Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"
] |
[
"PHA - Pharmacy"
] |
[
"155 - Drug Enforcement Administration (DEA)",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] |
2023-Q4
|
2014-09-01
| null |
NJ
|
US
| 354
| 0
| null |
2024-01-25T06:01:42.808429-05:00
|
RUBICON ADVISORS, LLC
|
1455 Pennsylvania Ave Ste 400, Washington, DC, 20004, US
| 315,091
|
Lobbying firm
|
WILLIAM BURKE
| 39,394
|
+1 202-652-2290
|
[
"WILLIAM BURKE"
] |
[
33519
] |
[
null
] |
[
false
] |
https://lda.senate.gov/api/v1/clients/185325/
|
https://lda.senate.gov/api/v1/registrants/315091/
|
https://lda.senate.gov/filings/public/filing/fd0cb46c-9798-4b16-a405-12c355ed7f75/print/
|
fd0cb46c-9798-4b16-a405-12c355ed7f75
|
fd0cb46c-9798-4b16-a405-12c355ed7f75_315091_185325
|
dr. reddy's laboratories, ltd
| 2024-01-25T10:47:09
|
512299
| 2012-09-01T00:00:00
|
sterling biotech limited
| null | 20,000
|
lobbying_income
|
service_provided
|
[
"health and FDA issues"
] |
[
"HCR - Health Issues"
] |
[
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2012-Q3
|
2012-09-01
| null | null |
IN
| 431
| 0
| null |
2024-04-08T10:42:19.089523-04:00
|
UPSTREAM CONSULTING
|
P.O. Box 159, Catharpin, VA, 20143, US
| 88,278
|
Government Relations
|
C. MCLAIN HADDOW
| 36,652
|
+1 571-294-5978
|
[
"JOHN M. HADDOW",
"MCCLAIN C HADDOW",
"YARDLY POLLAS-KIMBLE"
] |
[
64518,
68662,
55410
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/173889/
|
https://lda.senate.gov/api/v1/registrants/88278/
|
https://lda.senate.gov/filings/public/filing/78db920d-1936-4da6-9146-5485ca8c4ae9/print/
|
78db920d-1936-4da6-9146-5485ca8c4ae9
|
78db920d-1936-4da6-9146-5485ca8c4ae9_88278_173889
|
sterling biotech limited
| null |
512299
| 2012-09-01T00:00:00
|
sterling biotech limited
| null | 20,000
|
lobbying_income
|
service_provided
|
[
"health and FDA issues"
] |
[
"HCR - Health Issues"
] |
[
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2013-Q1
|
2012-09-01
| null | null |
IN
| 431
| 0
| null |
2024-04-08T10:42:19.089523-04:00
|
UPSTREAM CONSULTING
|
P.O. Box 159, Catharpin, VA, 20143, US
| 88,278
|
Government Relations
|
C. MCLAIN HADDOW
| 36,652
|
+1 571-294-5978
|
[
"JOHN M. HADDOW",
"MCCLAIN C HADDOW",
"YARDLY POLLAS-KIMBLE"
] |
[
64518,
68662,
55410
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/173889/
|
https://lda.senate.gov/api/v1/registrants/88278/
|
https://lda.senate.gov/filings/public/filing/ff77daa2-5f7c-4b23-801d-f75fcf2e304f/print/
|
ff77daa2-5f7c-4b23-801d-f75fcf2e304f
|
ff77daa2-5f7c-4b23-801d-f75fcf2e304f_88278_173889
|
sterling biotech limited
| null |
512299
| 2013-07-18T00:00:00
|
sterling biotech limited
| null | 5,000
|
lobbying_income
|
terminate_retainer
|
[] | null | null |
2013-Q2
|
2012-09-01
|
2013-04-01
| null |
IN
| 431
| 0
| null |
2024-04-08T10:42:19.089523-04:00
|
UPSTREAM CONSULTING
|
P.O. Box 159, Catharpin, VA, 20143, US
| 88,278
|
Government Relations
|
C. MCLAIN HADDOW
| 36,652
|
+1 571-294-5978
| null | null | null | null |
https://lda.senate.gov/api/v1/clients/173889/
|
https://lda.senate.gov/api/v1/registrants/88278/
|
https://lda.senate.gov/filings/public/filing/c383ef96-85bd-4d49-9c76-3ddb6973b306/print/
|
c383ef96-85bd-4d49-9c76-3ddb6973b306
|
c383ef96-85bd-4d49-9c76-3ddb6973b306_88278_173889
|
sterling biotech limited
| 2013-07-18T15:46:58
|
519105
| 2007-08-01T00:00:00
|
natural products association
| null | 14,400
|
lobbying_income
|
service_provided
|
[
"H.R. 2997/S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act,\nFY2010, provisions relating to dietary supplements. H.R. 3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act,\nFY2010, provisions relating to NIH\nH.R.2918, Legislative Branch Appropriations Act, FY2010, Division B Continuing Appropriations Resolution, provisions\nrelating to NIH; and dietary supplements\nH.R.2996, Department of the Interior, Environment, and Related Agencies Appropriations Act, FY2010, Division B is the\nFurther Continuing Appropriations Resolution, FY2010, Provisions relating to dietary supplements\nH.R.3288, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2010, the\nConsolidated Appropriations Act, FY2010, Provisions relating to dietary supplements",
"S. 510, FDA Food Safety Modernization Act - Entire bill as it relates to dietary supplements.\nH.R. 1332, Safe Food Enforcement, Assessment, Standards, and Targeting Act - Entire bill as it relates to dietary supplements.\nH.R. 2749, Food Safety Enhancement Act of 2009 - Entire bill as it relates to dietary supplements.\nH.R. 759, Food and Drug Administration Globalization Act of 2009 - Entire bill as it relates to dietary supplements. H.R. 875, Food Safety Modernization Act of 2009 - Entire bill as it relates to dietary supplements.\nH.R. 815/S. 425, Food Safety and Tracking Improvement Act - Entire bill as it relates to dietary supplements.\nS.429, Ending Agricultural Threats: Safeguarding America's Food for Everyone (EAT SAFE) Act of 2009, Entire bill as it relates\nto dietary supplements.\nS.1269, Food Safety Rapid Response Act, entire bill as it relates to dietary supplements.",
"Public Law 108-265, Child Nutrition and WIC Reauthorization Act of 2004 - Nutrition related issues.",
"S. 641, the Dehydroepiandrosterone Abuse Reduction Act of 2009 - Entire bill as it relates to dietary supplements.\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act - Entire bill as it relates to dietary\nsupplements. H.R. 1324/S. 934, Child Nutrition Promotion and School Lunch Protection Act of 2009 (Introduced in House) - Nutrition\nrelated issues.\nAmerica's Healthy Futures Act of 2009, prevention and wellness issues.\nH.R. 3200, America's Affordable Health Choices Act of 2009, prevention and wellness issues.\nS. 1679, Affordable Health Choices Act, prevention and wellness issues.\nH.R. 3406, Tax Equity for Meal Replacements and Supplements Act of 2009, Dietary supplement related issues.\nH.R.3962, Affordable Health Care for America Act, prevention and wellness issues.\nH.R.3590, Patient Protection and Affordable Care Act, prevention and wellness issues."
] |
[
"BUD - Budget/Appropriations",
"FOO - Food Industry (safety, labeling, etc.)",
"AGR - Agriculture",
"HCR - Health Issues"
] |
[
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2009-Q4
|
2007-08-01
| null |
CA
|
US
| 90
| 0
| null |
2022-04-06T16:07:40.637966-04:00
|
POLICY ADVOCATES
|
1200 North Nash Street, Suite 1165, Arlington, VA, 22209, US
| 72,018
|
Walker, Martin & Hatch provides regulatory and legislative consulting services.
|
JACK MARTIN
| 35,858
|
+1 202-543-9004
|
[
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN"
] |
[
36980,
36980,
36980,
36980
] |
[
null,
null,
null,
null
] |
[
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/165532/
|
https://lda.senate.gov/api/v1/registrants/72018/
|
https://lda.senate.gov/filings/public/filing/819a8715-7235-4a0c-91c6-80041a389987/print/
|
819a8715-7235-4a0c-91c6-80041a389987
|
819a8715-7235-4a0c-91c6-80041a389987_72018_165532
|
natural products association
| null |
519105
| 2007-08-01T00:00:00
|
natural products association
| null | 14,400
|
lobbying_income
|
modify_service
|
[
"Dehydroepiandrosterone Abuse Reduction, Issues regarding dietary supplements.\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary\nsupplement issues. Child Nutrition Promotion and School Lunch Protection, Nutrition related issues.\nTax Equity for Meal Replacements and Supplements, Issues regarding dietary supplements.",
"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2012 provisions relating to\ndietary supplements.\nDepartments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, rovisions relating\nto NIH. Public Law 112-4, Further Continuing Appropriations Amendments, FY2011, provisions related to dietary supplements.\nPublic Law 112-6, Additional Continuing Appropriations Amendments, FY2011, provisions related to dietary supplements.\nH.R.1/S.Amdt. 149, Full-Year Continuing Appropriations Act, FY2011, provisions related to dietary supplements.\nPublic Law 111-322, Continuing Appropriations and Surface Transportation Extension Act, FY2011, provisions related to\ndietary supplements.",
"Public Law 111-353, FDA Food Safety Modernization Act, Implementation issues regarding dietary supplement issues.\nS.216, Food Safety Accountability Act of 2011, entire bill as it relates to dietary supplements.",
"Designer Anabolic Steroid Control, Dietary supplement issues.\nDehydroepiandrosterone Abuse Reduction, Dietary supplement issues.\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary\nsupplement issues. S.605/H.R.1254, Dangerous Synthetic Drug Control Act of 2011, entire bill as it relates to dietary supplements.\nS.409, Combating Dangerous Synthetic Stimulants Act of 2011, entire bill as it relates to dietary supplements.",
"Public Law 111-296, Healthy, Hunger-Free Kids Act of 2010, Implementation issues regarding Nutrition issues."
] |
[
"HCR - Health Issues",
"BUD - Budget/Appropriations",
"FOO - Food Industry (safety, labeling, etc.)",
"LAW - Law Enforcement/Crime/Criminal Justice",
"AGR - Agriculture"
] |
[
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q1
|
2007-08-01
| null |
CA
|
US
| 90
| 0
| null |
2022-04-06T16:07:40.637966-04:00
|
POLICY ADVOCATES
|
1200 North Nash Street, Suite 1165, Arlington, VA, 22209, US
| 72,018
|
Walker, Martin & Hatch provides regulatory and legislative consulting services.
|
JACK MARTIN
| 35,858
|
+1 202-543-9004
|
[
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN"
] |
[
36980,
36980,
36980,
36980,
36980
] |
[
null,
null,
null,
null,
null
] |
[
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/165532/
|
https://lda.senate.gov/api/v1/registrants/72018/
|
https://lda.senate.gov/filings/public/filing/a6668e72-9a07-48e1-9906-a43b24d969f6/print/
|
a6668e72-9a07-48e1-9906-a43b24d969f6
|
a6668e72-9a07-48e1-9906-a43b24d969f6_72018_165532
|
natural products association
| null |
519105
| 2007-08-01T00:00:00
|
natural products association
| null | 14,400
|
lobbying_income
|
service_provided
|
[
"Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary\nsupplement issues\nH.R.2044, Health Freedom Act, Issues regarding dietary supplements",
"H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.\nPublic Law 111-296, Healthy, Hunger-Free Kids Act of 2010, Implementation issues regarding Nutrition\nH.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations\nS.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012",
"Public Law 111-353, FDA Food Safety Modernization Act, Implementation issues regarding dietary supplement issues\nS.216, Food Safety Accountability Act of 2011, entire bill as it relates to dietary supplements\nS.1310, Dietary Supplement Labeling Act, entire bill as it relates to dietary supplements\nH.R.1364, Free Speech About Science Act, entire bill as it relates to dietary supplements",
"Designer Anabolic Steroid Control Act, Dietary supplement issues\nDehydroepiandrosterone Abuse Reduction Act, Dietary supplement issues\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary\nsupplement issues S.605/H.R.1254, Dangerous Synthetic Drug Control Act of 2011, entire bill as it relates to dietary supplements\nS.409, Combating Dangerous Synthetic Stimulants Act of 2011, entire bill as it relates to dietary supplements"
] |
[
"HCR - Health Issues",
"CSP - Consumer Issues/Safety/Products",
"FOO - Food Industry (safety, labeling, etc.)",
"LAW - Law Enforcement/Crime/Criminal Justice"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q4
|
2007-08-01
| null |
CA
|
US
| 90
| 0
| null |
2022-04-06T16:07:40.637966-04:00
|
POLICY ADVOCATES
|
1200 North Nash Street, Suite 1165, Arlington, VA, 22209, US
| 72,018
|
Walker, Martin & Hatch provides regulatory and legislative consulting services.
|
JACK MARTIN
| 35,858
|
+1 202-543-9004
|
[
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN"
] |
[
36980,
36980,
36980,
36980
] |
[
null,
null,
null,
null
] |
[
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/165532/
|
https://lda.senate.gov/api/v1/registrants/72018/
|
https://lda.senate.gov/filings/public/filing/6975e6b6-d1c6-4eab-abb3-3c31c59b59de/print/
|
6975e6b6-d1c6-4eab-abb3-3c31c59b59de
|
6975e6b6-d1c6-4eab-abb3-3c31c59b59de_72018_165532
|
natural products association
| null |
519105
| 2008-04-14T00:00:00
|
natural products association
| null | 14,400
|
lobbying_income
|
service_provided
|
[
"S.770: Food Stamp Vitamin and Mineral Improvement Act; entire bill as it relates to dietary supplements.\nS.771/HR1363: The Child Nutrition Promotion and School Lunch Protection Act; entire bill as it relates to dietary supplements.\nS.762/HR1249: A bill to include dehydroepiandrosterone as an anabolic steroid; entire bill as it relates to dietary supplements.\nHR1107: Dietary Supplement and Healthy Meal Replacement Tax Parity Act; entire bill as it relates to dietary supplements. S2470: Dehydroepiandrosterone Abuse Reduction Act of 2007; entire bill as it relates to dietary supplements.\nS1274/HR2108: Human and Pet Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\nS1776: Imported Food Security Act of 2007; all provisions affecting the dietary supplement industry.\nS2245: Food Safety Authority Modernization Act; all provisions affecting the dietary supplement industry.\nHR3937: Food Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\nHR3610: Food and Drug Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\nHR3624: Consumer Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\nS.654/HR1148: Safe Food Act of 2007; all provisions affecting the dietary supplement industry.",
"Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for 2009, Title II, all provisions relating to dietary supplements, and complementry and alternative medicine.\nAgriculture, Rural Development, FDA, and Related Agencies Appropriations Act for 2009, all provisions relating to dietary supplements.",
"HR2419/S.2302, Farm Bill Extension Act of 2007; all provisions relating to dietary supplements."
] |
[
"HCR - Health Issues",
"BUD - Budget/Appropriations",
"AGR - Agriculture"
] |
[
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q1
|
2007-08-01
| null |
CA
|
US
| 90
| 0
| null |
2022-04-06T16:07:40.637966-04:00
|
POLICY ADVOCATES
|
1200 North Nash Street, Suite 1165, Arlington, VA, 22209, US
| 72,018
|
Walker, Martin & Hatch provides regulatory and legislative consulting services.
|
JACK MARTIN
| 35,858
|
+1 202-543-9004
|
[
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN"
] |
[
36980,
36980,
36980
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/165532/
|
https://lda.senate.gov/api/v1/registrants/72018/
|
https://lda.senate.gov/filings/public/filing/85800ffd-b8df-4521-893d-f51d21efcd6f/print/
|
85800ffd-b8df-4521-893d-f51d21efcd6f
|
85800ffd-b8df-4521-893d-f51d21efcd6f_72018_165532
|
natural products association
| 2008-04-14T15:01:17
|
519105
| 2008-04-18T00:00:00
|
natural products association
| null | 20,000
|
lobbying_income
|
service_provided
|
[
"H.R. 2419/S. 2302, Farm Bill Extension Act of 2007; Title IV, as well as all provisions relating to dietary supplements.",
"S. 770: Food Stamp Vitamin and Mineral Improvement Act; entire bill as it relates to dietary supplements.\nS. 771/ H.R. 1363: The Child Nutrition Promotion and School Lunch Protection Act; entire bill as it relates to dietary supplements.\nS. 762/H.R. 1249: A bill to include dehydroepiandrosterone as an anabolic steroid; entire bill as it relates to dietary supplements. H.R. 1107: Dietary Supplement and Healthy Meal Replacement Tax Parity Act; entire bill as it relates to dietary supplements.\n\nS. 2470: Dehydroepiandrosterone Abuse Reduction Act of 2007; entire bill as it relates to dietary supplements.\n\nH.R. 3610: Food and Drug Import Safety Act of 2007; all provisions affecting the dietary supplement industry. \n\nS. 1274/H.R. 2108: Human and Pet Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 1776: Imported Food Security Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 2245: Food Safety Authority Modernization Act; all provisions affecting the dietary supplement industry.\n\nH.R. 3937: Food Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nH.R. 3624, Consumer Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 654/H.R. 1148, Safe Food Act of 2007; all provisions affecting the dietary supplement industry.",
"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for 2009, Title II, all provisions relating to dietary supplements, and complementary and alternative medicine. \nAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for 2009, all provisions relating to dietary supplements."
] |
[
"AGR - Agriculture",
"HCR - Health Issues",
"BUD - Budget/Appropriations"
] |
[
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q1
|
2007-08-08
| null |
DC
|
US
| 416
| 0
| 0
|
2024-02-15T12:14:21.586985-05:00
|
CAPITOL ASSOCIATES, INC.
|
1009 Duke Street, Alexandria, VA, 22314, US
| 8,101
|
Government Relations Health Policy Consulting Firm
|
NATHANIEL BAUGH
| 30,813
|
+1 202-544-1880
|
[
"KATHERINE VANLANDINGHAM",
"KATHERINE VANLANDINGHAM",
"KATHERINE VANLANDINGHAM"
] |
[
12071,
12071,
12071
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/111122/
|
https://lda.senate.gov/api/v1/registrants/8101/
|
https://lda.senate.gov/filings/public/filing/247b0c7c-b901-4bd9-9288-029226898ac1/print/
|
247b0c7c-b901-4bd9-9288-029226898ac1
|
247b0c7c-b901-4bd9-9288-029226898ac1_8101_111122
|
natural products association
| 2008-04-18T13:51:06
|
519105
| 2008-07-14T00:00:00
|
natural products association
| null | 14,400
|
lobbying_income
|
service_provided
|
[
"HR2419/S.2302, Farm Bill Extension Act of 2007; all provisions relating to dietary supplements.\nH.R. 6124: Food, Conservation, and Energy Act of 2008; Title IV, as well as all provisions relating to dietary supplements.",
"S.770: Food Stamp Vitamin and Mineral Improvement Act; entire bill as it relates to dietary supplements.\nS.771/HR1363: The Child Nutrition Promotion and School Lunch Protection Act; entire bill as it relates to dietary supplements.\nS.762/HR1249: A bill to include dehydroepiandrosterone as an anabolic steroid; entire bill as it relates to dietary supplements.\nHR1107: Dietary Supplement and Healthy Meal Replacement Tax Parity Act; entire bill as it relates to dietary supplements. S2470: Dehydroepiandrosterone Abuse Reduction Act of 2007; entire bill as it relates to dietary supplements.\nS1274/HR2108: Human and Pet Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\nS1776: Imported Food Security Act of 2007; all provisions affecting the dietary supplement industry.\nS2245: Food Safety Authority Modernization Act; all provisions affecting the dietary supplement industry.\nHR3937: Food Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\nHR3610: Food and Drug Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\nHR3624: Consumer Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\nS.654/HR1148: Safe Food Act of 2007; all provisions affecting the dietary supplement industry.\nH.R. 5904: Safe Food Enforcement, Assessment, Standards and Targeting Act of 2008; all provisions affecting the dietary supplement industry.",
"Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for 2009, Title II, all provisions relating to dietary supplements, and complementry and alternative medicine.\nAgriculture, Rural Development, FDA, and Related Agencies Appropriations Act for 2009, all provisions relating to dietary supplements. H.R. 2642: The Supplemental Appropriations Act, 2008, Title II, track and monitor funding for the Food and Drug Administration."
] |
[
"AGR - Agriculture",
"HCR - Health Issues",
"BUD - Budget/Appropriations"
] |
[
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q2
|
2007-08-01
| null |
CA
|
US
| 90
| 0
| null |
2022-04-06T16:07:40.637966-04:00
|
POLICY ADVOCATES
|
1200 North Nash Street, Suite 1165, Arlington, VA, 22209, US
| 72,018
|
Walker, Martin & Hatch provides regulatory and legislative consulting services.
|
JACK MARTIN
| 35,858
|
+1 202-543-9004
|
[
"JACK MARTIN",
"JACK MARTIN",
"JACK MARTIN"
] |
[
36980,
36980,
36980
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/165532/
|
https://lda.senate.gov/api/v1/registrants/72018/
|
https://lda.senate.gov/filings/public/filing/90fa3477-ba5f-4dc6-ae11-8d9cd8313bf7/print/
|
90fa3477-ba5f-4dc6-ae11-8d9cd8313bf7
|
90fa3477-ba5f-4dc6-ae11-8d9cd8313bf7_72018_165532
|
natural products association
| 2008-07-14T16:03:51
|
519105
| 2008-07-18T00:00:00
|
natural products association
| null | 20,000
|
lobbying_income
|
service_provided
|
[
"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for 2009, Title II, all provisions relating to dietary supplements, and complementary and alternative medicine. \nAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for 2009, all provisions relating to dietary supplements. H.R. 2642: The Supplemental Appropriations Act, 2008, Title II, track and monitor funding for the Food and Drug Administration.",
"S. 770: Food Stamp Vitamin and Mineral Improvement Act; entire bill as it relates to dietary supplements.\nS. 771/ H.R. 1363: The Child Nutrition Promotion and School Lunch Protection Act; entire bill as it relates to dietary supplements.\nS. 762/H.R. 1249: A bill to include dehydroepiandrosterone as an anabolic steroid; entire bill as it relates to dietary supplements. H.R. 1107: Dietary Supplement and Healthy Meal Replacement Tax Parity Act; entire bill as it relates to dietary supplements.\n\nS. 2470: Dehydroepiandrosterone Abuse Reduction Act of 2007; entire bill as it relates to dietary supplements.\n\nH.R. 3610: Food and Drug Import Safety Act of 2007; all provisions affecting the dietary supplement industry. \n\nS. 1274/H.R. 2108: Human and Pet Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 1776: Imported Food Security Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 2245: Food Safety Authority Modernization Act; all provisions affecting the dietary supplement industry.\n\nH.R. 3937: Food Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nH.R. 3624: Consumer Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 654/H.R. 1148: Safe Food Act of 2007; all provisions affecting the dietary supplement industry.\n\nH.R. 5904: Safe Food Enforcement, Assessment, Standards and Targeting Act of 2008; all provisions affecting the dietary supplement industry.",
"H.R. 2419/S. 2302: Farm Bill Extension Act of 2007; Title IV, as well as all provisions relating to dietary supplements.\nH.R. 6124: Food, Conservation, and Energy Act of 2008; Title IV, as well as all provisions relating to dietary supplements."
] |
[
"BUD - Budget/Appropriations",
"HCR - Health Issues",
"AGR - Agriculture"
] |
[
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q2
|
2007-08-08
| null |
DC
|
US
| 416
| 0
| 0
|
2024-02-15T12:14:21.586985-05:00
|
CAPITOL ASSOCIATES, INC.
|
1009 Duke Street, Alexandria, VA, 22314, US
| 8,101
|
Government Relations Health Policy Consulting Firm
|
NATHANIEL BAUGH
| 30,813
|
+1 202-544-1880
|
[
"KATHERINE VANLANDINGHAM",
"KATHERINE VANLANDINGHAM",
"KATHERINE VANLANDINGHAM"
] |
[
12071,
12071,
12071
] |
[
null,
null,
null
] |
[
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/111122/
|
https://lda.senate.gov/api/v1/registrants/8101/
|
https://lda.senate.gov/filings/public/filing/14ebe724-378f-4481-8305-bf7f7d48f70f/print/
|
14ebe724-378f-4481-8305-bf7f7d48f70f
|
14ebe724-378f-4481-8305-bf7f7d48f70f_8101_111122
|
natural products association
| 2008-07-18T17:17:48
|
519105
| 2008-10-14T00:00:00
|
natural products association
| null | 14,400
|
lobbying_income
|
service_provided
|
[
"S.770: Food Stamp Vitamin and Mineral Improvement Act; entire bill as it relates to dietary supplements.\nS.771/HR1363: The Child Nutrition Promotion and School Lunch Protection Act; entire bill as it relates to dietary supplements.\nS.762/HR1249: A bill to include dehydroepiandrosterone as an anabolic steroid; entire bill as it relates to dietary supplements.\nHR1107: Dietary Supplement and Healthy Meal Replacement Tax Parity Act; entire bill as it relates to dietary supplements. S2470: Dehydroepiandrosterone Abuse Reduction Act of 2007; entire bill as it relates to dietary supplements.\nS1274/HR2108: Human and Pet Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\nS1776: Imported Food Security Act of 2007; all provisions affecting the dietary supplement industry.\nS2245: Food Safety Authority Modernization Act; all provisions affecting the dietary supplement industry.\nHR3937: Food Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\nHR3610: Food and Drug Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\nHR3624: Consumer Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\nS.654/HR1148: Safe Food Act of 2007; all provisions affecting the dietary supplement industry.\nH.R. 5904: Safe Food Enforcement, Assessment, Standards and Targeting Act of 2008; all provisions affecting the dietary supplement industry.",
"Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for 2009, Title II, all provisions relating to dietary supplements, and complementry and alternative medicine.\nAgriculture, Rural Development, FDA, and Related Agencies Appropriations Act for 2009, all provisions relating to dietary supplements. H.R. 2642: The Supplemental Appropriations Act, 2008, Title II, track and monitor funding for the Food and Drug Administration.\nS. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for 2009, Title II, all provisions relating to dietary supplements, and complementary and alternative medicine. \nS. 3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for 2009, all provisions relating to dietary supplements.\nH.R. 2638: Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009; Division A, continuing appropriations funding for the Departments of Labor, Health and Human Services, and Education, and Related Agencies and the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies until March 6, 2009."
] |
[
"HCR - Health Issues",
"BUD - Budget/Appropriations"
] |
[
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q3
|
2007-08-01
| null |
CA
|
US
| 90
| 0
| null |
2022-04-06T16:07:40.637966-04:00
|
POLICY ADVOCATES
|
1200 North Nash Street, Suite 1165, Arlington, VA, 22209, US
| 72,018
|
Walker, Martin & Hatch provides regulatory and legislative consulting services.
|
JACK MARTIN
| 35,858
|
+1 202-543-9004
|
[
"JACK MARTIN",
"JACK MARTIN"
] |
[
36980,
36980
] |
[
null,
null
] |
[
false,
false
] |
https://lda.senate.gov/api/v1/clients/165532/
|
https://lda.senate.gov/api/v1/registrants/72018/
|
https://lda.senate.gov/filings/public/filing/74bcd20d-59b1-43f4-b98c-8135356873a5/print/
|
74bcd20d-59b1-43f4-b98c-8135356873a5
|
74bcd20d-59b1-43f4-b98c-8135356873a5_72018_165532
|
natural products association
| 2008-10-14T14:38:58
|
519105
| 2008-10-17T00:00:00
|
natural products association
| null | 20,000
|
lobbying_income
|
service_provided
|
[
"S. 770: Food Stamp Vitamin and Mineral Improvement Act; entire bill as it relates to dietary supplements.\nS. 771/ H.R. 1363: The Child Nutrition Promotion and School Lunch Protection Act; entire bill as it relates to dietary supplements.\nS. 762/H.R. 1249: A bill to include dehydroepiandrosterone as an anabolic steroid; entire bill as it relates to dietary supplements. H.R. 1107: Dietary Supplement and Healthy Meal Replacement Tax Parity Act; entire bill as it relates to dietary supplements.\n\nS. 2470: Dehydroepiandrosterone Abuse Reduction Act of 2007; entire bill as it relates to dietary supplements.\n\nH.R. 3610: Food and Drug Import Safety Act of 2007; all provisions affecting the dietary supplement industry. \n\nS. 1274/H.R. 2108: Human and Pet Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 1776: Imported Food Security Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 2245: Food Safety Authority Modernization Act; all provisions affecting the dietary supplement industry.\n\nH.R. 3937: Food Import Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nH.R. 3624: Consumer Food Safety Act of 2007; all provisions affecting the dietary supplement industry.\n\nS. 654/H.R. 1148: Safe Food Act of 2007; all provisions affecting the dietary supplement industry.\n\nH.R. 5904: Safe Food Enforcement, Assessment, Standards and Targeting Act of 2008; all provisions affecting the dietary supplement industry.",
"S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for 2009, Title II, all provisions relating to dietary supplements, and complementary and alternative medicine. \nS. 3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for 2009, all provisions relating to dietary supplements. H.R. 2638: Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009; Division A, continuing appropriations funding for the Departments of Labor, Health and Human Services, and Education, and Related Agencies and the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies until March 6, 2009."
] |
[
"HCR - Health Issues",
"BUD - Budget/Appropriations"
] |
[
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2008-Q3
|
2007-08-08
| null |
DC
|
US
| 416
| 0
| 0
|
2024-02-15T12:14:21.586985-05:00
|
CAPITOL ASSOCIATES, INC.
|
1009 Duke Street, Alexandria, VA, 22314, US
| 8,101
|
Government Relations Health Policy Consulting Firm
|
NATHANIEL BAUGH
| 30,813
|
+1 202-544-1880
|
[
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"EDWARD LONG",
"KATHERINE VANLANDINGHAM"
] |
[
46333,
12071,
46333,
12071
] |
[
null,
null,
null,
null
] |
[
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/111122/
|
https://lda.senate.gov/api/v1/registrants/8101/
|
https://lda.senate.gov/filings/public/filing/226c8478-7d65-4180-ad9a-0c95d82a9381/print/
|
226c8478-7d65-4180-ad9a-0c95d82a9381
|
226c8478-7d65-4180-ad9a-0c95d82a9381_8101_111122
|
natural products association
| 2008-10-17T14:47:15
|
519105
| 2009-01-08T00:00:00
|
natural products association
|
Non-profit organization dedicated to the Natural Products Industry.
| 10,000
|
lobbying_income
|
service_provided
|
[
"PL 108-265, Child Nutrition and WIC Reauthorization Act of 2004, Nutrition related issues.",
"S. 641, Dehydroepiandrosterone Abuse Reduction Act of 2009, entire bill as it relates to dietary supplements\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, entire bill as it relates to dietary supplements H.R.1324/S.934, Child Nutrition Promotion and School Lunch Protection Act, Nutrition related issues. \n\nAmerica's Healthy Futures Act of 2009, prevention and wellness issues\n\nH.R.3200, America's Affordable Health Choices Act of 2009, prevention and wellness issues\n\nS.1679, Affordable Health Choices Act, prevention and wellness issues\n\nH.R.3406, Tax Equity for Meal Replacements and Supplements Act of 2009, Dietary supplement related issues.\n\nH.R.3962, Affordable Health Care for America Act, Prevention and wellness issues\n\nH.R.3590, Patient Protection and Affordable Care Act, Prevention and wellness issues",
"H.R.2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, provisions relating to dietary supplements \nH.R.3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH H.R.2918, Legislative Branch Appropriations Act, FY2010, Division B Continuing Appropriations Resolution, provisions relating to dietary supplements\n\nH.R.2996, Department of the Interior, Environment, and Related Agencies Appropriations Act, FY2010, Division B is the\nFurther Continuing Appropriations Resolution, FY2010, Provisions relating to dietary supplements\n\nH.R.3288, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2010, the\nConsolidated Appropriations Act, FY2010, Provisions relating to dietary supplements",
"S. 510, FDA Food Safety Modernization Act, entire bill as it relates to dietary supplements\nH.R. 1332, Safe Food Enforcement, Assessment, Standards, and Targeting Act, entire bill as it relates to dietary supplements\nH.R. 759, Food and Drug Administration Globalization Act of 2009, entire bill as it relates to dietary supplements\nH.R.2749, Food Safety Enhancement Act of 2009, entire bill as it relates to dietary supplements H.R. 875, Food Safety Modernization Act of 2009, entire bill as it relates to dietary supplements\n\nS. 425/H.R.815, Food Safety and Tracking Improvement Act, entire bill as it relates to dietary supplements\n\nS.429, Ending Agricultural Threats: Safeguarding America's Food for Everyone (EAT SAFE) Act of 2009, Entire bill as it relates to dietary supplements.\n\nS.1269, Food Safety Rapid Response Act, entire bill as it relates to dietary supplements."
] |
[
"AGR - Agriculture",
"HCR - Health Issues",
"BUD - Budget/Appropriations",
"FOO - Food Industry (safety, labeling, etc.)"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2009-Q4
|
2009-01-08
| null |
DC
|
US
| 1,005,650
| 0
| 0
|
2024-01-30T15:11:29.713945-05:00
|
VAN SCOYOC ASSOCIATES
|
800 Maine Avenue, SW, Suite 800, Washington, DC, 20024, US
| 39,837
|
Government Relations Consultant
|
H. STEWART VAN SCOYOC
| 32,802
|
+1 202-638-1950
|
[
"EDWARD LONG (StaffDir,SenSubcommOnLabor,HHS,Ed Approps)",
"H STEWART VAN SCOYOC",
"KATHERINE VANLANDINGHAM (LegAsst/CorrespDir, Senator Sam Brownback)",
"EDWARD LONG (StaffDir,SenSubcommOnLabor,HHS,Ed Approps)",
"H STEWART VAN SCOYOC",
"KATHERINE VANLANDINGHAM (LegAsst/CorrespDir, Senator Sam Brownback)",
"EDWARD LONG (StaffDir,SenSubcommOnLabor,HHS,Ed Approps)",
"H STEWART VAN SCOYOC",
"KATHERINE VANLANDINGHAM (LegAsst/CorrespDir, Senator Sam Brownback)",
"EDWARD LONG (StaffDir,SenSubcommOnLabor,HHS,Ed Approps)",
"H STEWART VAN SCOYOC",
"KATHERINE VANLANDINGHAM (LegAsst/CorrespDir, Senator Sam Brownback)"
] |
[
54690,
12433,
46253,
54690,
12433,
46253,
54690,
12433,
46253,
54690,
12433,
46253
] |
[
"StaffDir,SenSubcommOnLabor,HHS,Ed Approps",
null,
"LegAsst/CorrespDir, Senator Sam Brownback",
"StaffDir,SenSubcommOnLabor,HHS,Ed Approps",
null,
"LegAsst/CorrespDir, Senator Sam Brownback",
"StaffDir,SenSubcommOnLabor,HHS,Ed Approps",
null,
"LegAsst/CorrespDir, Senator Sam Brownback",
"StaffDir,SenSubcommOnLabor,HHS,Ed Approps",
null,
"LegAsst/CorrespDir, Senator Sam Brownback"
] |
[
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/148285/
|
https://lda.senate.gov/api/v1/registrants/39837/
|
https://lda.senate.gov/filings/public/filing/d9f44796-144f-4faf-83ee-fdec1331a9eb/print/
|
d9f44796-144f-4faf-83ee-fdec1331a9eb
|
d9f44796-144f-4faf-83ee-fdec1331a9eb_39837_148285
|
natural products association
| null |
519105
| 2009-01-08T00:00:00
|
natural products association
|
Non-profit organization dedicated to the Natural Products Industry.
| 20,000
|
lobbying_income
|
service_provided
|
[
"Public Law 111-296, Healthy, Hunger-Free Kids Act of 2010, Implementation issues regarding Nutrition",
"H.R.2010/S.1098, Family and Retirement Health Investment Act of 2011, Dietary supplement issues.",
"Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues\nH.R.2044, Health Freedom Act, Issues regarding dietary supplements",
"H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2012 provisions relating to dietary supplements \nS.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, rovisions relating to NIH Monitor the following:\n Public Law 112-33, Continuing Appropriations Act, 2012 (through 10/4/11)\n Public Law 112-36, Continuing Appropriations Act, 2012 (through 11/18/11)\n Public Law 112-67, 4th FY2012 Continuing Resolution (through December 17, 2011)\n Public Law 112-68, 5th FY2012 Continuing Resolution (through December 23, 2011)\n Public Law 112-25, Budget Control Act of 2011\n\nPublic Law 112-74, Consolidated Appropriations Act, FY2012, provisions relating to NIH\nPublic Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012, provisions relating to dietary supplements",
"Public Law 111-353, FDA Food Safety Modernization Act, Implementation issues regarding dietary supplement issues\nS.216, Food Safety Accountability Act of 2011, entire bill as it relates to dietary supplements\nS.1310, Dietary Supplement Labeling Act, entire bill as it relates to dietary supplements\nH.R.1364, Free Speech About Science Act, entire bill as it relates to dietary supplements H.R.2359, Safe Cosmetics Act, entire bill as it relates to dietary supplements\n\nH.R.3380, Dietary Supplement Protection Act of 2011, entire bill as it relates to dietary supplements",
"Designer Anabolic Steroid Control Act, Dietary supplement issues\nDehydroepiandrosterone Abuse Reduction Act, Dietary supplement issues\nPublic Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues S.605/H.R.1254, Dangerous Synthetic Drug Control Act of 2011, entire bill as it relates to dietary supplements\n\nS.409, Combating Dangerous Synthetic Stimulants Act of 2011, entire bill as it relates to dietary supplements",
"H.R.2045, Freedom of Health Speech Act, Dietary supplement issues."
] |
[
"AGR - Agriculture",
"TAX - Taxation/Internal Revenue Code",
"HCR - Health Issues",
"BUD - Budget/Appropriations",
"FOO - Food Industry (safety, labeling, etc.)",
"LAW - Law Enforcement/Crime/Criminal Justice",
"ADV - Advertising"
] |
[
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] |
2011-Q4
|
2009-01-08
| null |
DC
|
US
| 1,005,650
| 0
| 0
|
2024-01-30T15:11:29.713945-05:00
|
VAN SCOYOC ASSOCIATES
|
800 Maine Avenue, SW, Suite 800, Washington, DC, 20024, US
| 39,837
|
Government Relations Consultant
|
H. STEWART VAN SCOYOC
| 32,802
|
+1 202-638-1950
|
[
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"H STEWART VAN SCOYOC",
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"H STEWART VAN SCOYOC",
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"H STEWART VAN SCOYOC",
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"H STEWART VAN SCOYOC",
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"H STEWART VAN SCOYOC",
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"H STEWART VAN SCOYOC",
"EDWARD LONG",
"KATHERINE VANLANDINGHAM",
"H STEWART VAN SCOYOC"
] |
[
54690,
46253,
12433,
54690,
46253,
12433,
54690,
46253,
12433,
54690,
46253,
12433,
54690,
46253,
12433,
54690,
46253,
12433,
54690,
46253,
12433
] |
[
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] |
[
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] |
https://lda.senate.gov/api/v1/clients/148285/
|
https://lda.senate.gov/api/v1/registrants/39837/
|
https://lda.senate.gov/filings/public/filing/5afb7291-7556-4553-92c8-31bdae93ec64/print/
|
5afb7291-7556-4553-92c8-31bdae93ec64
|
5afb7291-7556-4553-92c8-31bdae93ec64_39837_148285
|
natural products association
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.